Earnings Feed
Start Free
Home/Filings/4/0000899243-20-018601
4//SEC Filing

GOLD DANIEL P PHD 4

Accession 0000899243-20-018601

CIK 0001262104other
View on SEC.govCompany Profile

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 12:44 PM ET

Size

15.7 KB

Accession

0000899243-20-018601

Insider Transaction Report

Form 4
Period: 2020-07-02
MEI Pharma, Inc.MEIP
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
  • Award

    Common Stock

    2020-07-02+80,000→ 441,632 total
  • Award

    Stock Option (Right to Buy)

    2020-07-02+680,000→ 680,000 total
    Exercise: $3.49Exp: 2030-07-02→ Common Stock (680,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $1.57Exp: 2025-07-28→ Common Stock (287,500 underlying)
    287,500

  • Stock Option (Right to Buy)

    Exercise: $4.33Exp: 2028-06-22→ Common Stock (380,000 underlying)
    380,000

  • Stock Option (Right to Buy)

    Exercise: $4.28Exp: 2028-07-12→ Common Stock (300,000 underlying)
    300,000

  • Stock Option (Right to Buy)

    Exercise: $1.36Exp: 2026-07-29→ Common Stock (380,000 underlying)
    380,000

  • Stock Option (Right to Buy)

    Exercise: $2.83Exp: 2027-07-06→ Common Stock (380,000 underlying)
    380,000

  • Stock Option (Right to Buy)

    Exercise: $2.52Exp: 2029-07-01→ Common Stock (680,000 underlying)
    680,000
Footnotes (8)
  • [F1]Consists of a grant of restricted stock units, which shall vest on the one-year anniversary of the date of grant.
  • [F2]One-quarter of such options shall vest on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
  • [F3]All of such options are presently exercisable.
  • [F4]One-quarter of such options vested on July 29, 2017 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 29, 2017.
  • [F5]One-quarter of such options vested on July 6, 2018 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 6, 2018.
  • [F6]One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
  • [F7]One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
  • [F8]One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

→
Entity typeother

Related Parties

1
  • filerCIK 0001288233

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 12:44 PM ET
Size
15.7 KB
View on SEC.gov